Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Cathy Bradley

Concepts (501)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Employment
41
2025
188
10.410
Why?
Neoplasms
72
2025
2884
9.520
Why?
Medicaid
37
2023
462
7.660
Why?
Cancer Survivors
17
2025
327
5.170
Why?
Breast Neoplasms
49
2024
2456
5.150
Why?
Insurance Coverage
22
2024
239
4.290
Why?
Medicare
36
2025
887
3.920
Why?
Insurance, Health
20
2024
303
3.570
Why?
Cost of Illness
14
2024
321
3.180
Why?
SEER Program
22
2024
224
3.090
Why?
Poverty
13
2022
530
2.790
Why?
Medically Uninsured
12
2020
129
2.440
Why?
Colorectal Neoplasms
16
2025
848
2.340
Why?
Healthcare Disparities
14
2020
728
2.340
Why?
United States
97
2025
15988
2.270
Why?
Uterine Cervical Neoplasms
7
2020
269
2.220
Why?
Health Services Accessibility
18
2024
1099
2.190
Why?
Survivors
17
2022
520
2.070
Why?
Early Detection of Cancer
10
2024
466
2.060
Why?
Medical Oncology
6
2024
332
1.960
Why?
Registries
33
2026
2385
1.840
Why?
Health Benefit Plans, Employee
5
2022
26
1.810
Why?
Antineoplastic Agents
9
2025
2197
1.760
Why?
Health Care Costs
14
2024
427
1.760
Why?
Humans
205
2026
144957
1.730
Why?
Carcinoma, Non-Small-Cell Lung
6
2025
1182
1.720
Why?
Survivorship
4
2022
54
1.560
Why?
Drug Costs
4
2025
116
1.500
Why?
Health Care Reform
4
2021
110
1.430
Why?
Lung Neoplasms
11
2025
2642
1.410
Why?
Caregivers
6
2023
1049
1.400
Why?
Aged
77
2025
25947
1.270
Why?
Female
130
2026
78376
1.250
Why?
Colonic Neoplasms
5
2016
260
1.250
Why?
Policy
4
2024
147
1.180
Why?
Prostatic Neoplasms
11
2022
978
1.170
Why?
Research
6
2022
431
1.170
Why?
Middle Aged
79
2026
35928
1.160
Why?
Mental Health
4
2023
792
1.150
Why?
Socioeconomic Factors
20
2022
1327
1.140
Why?
Michigan
24
2015
136
1.140
Why?
Prescription Drugs
2
2023
111
1.100
Why?
Income
8
2024
202
1.080
Why?
Efficiency
7
2016
104
1.050
Why?
Neoplasm Staging
17
2022
1465
1.040
Why?
Male
99
2026
72406
1.030
Why?
Health Status
10
2013
836
1.000
Why?
Aged, 80 and over
37
2025
8279
0.970
Why?
Medical Record Linkage
2
2021
68
0.970
Why?
Health Status Disparities
2
2023
321
0.960
Why?
Papanicolaou Test
2
2017
35
0.960
Why?
Adult
69
2026
40506
0.950
Why?
Primary Health Care
6
2023
1734
0.890
Why?
Motivation
2
2020
610
0.860
Why?
Occupational Medicine
1
2024
14
0.840
Why?
Safety-net Providers
3
2017
126
0.840
Why?
Cancer Care Facilities
4
2024
48
0.840
Why?
Medicare Part C
1
2025
31
0.830
Why?
Patient Acceptance of Health Care
4
2018
886
0.810
Why?
Eligibility Determination
5
2018
68
0.800
Why?
Comorbidity
12
2019
1660
0.780
Why?
Communication
3
2024
967
0.780
Why?
Quality of Life
8
2023
3192
0.770
Why?
Colonoscopy
4
2019
261
0.750
Why?
Health Expenditures
8
2023
194
0.750
Why?
Return to Work
4
2022
21
0.740
Why?
Absenteeism
4
2013
53
0.730
Why?
Virginia
7
2018
55
0.700
Why?
Mass Screening
10
2022
1348
0.700
Why?
Occupational Health
1
2024
209
0.680
Why?
Focus Groups
1
2024
573
0.680
Why?
Medication Adherence
2
2023
539
0.660
Why?
Workplace
4
2021
274
0.660
Why?
Young Adult
27
2026
14126
0.660
Why?
Mammography
5
2024
166
0.650
Why?
Cost Sharing
1
2020
20
0.620
Why?
Models, Economic
2
2011
62
0.610
Why?
Health Equity
1
2022
129
0.610
Why?
Information Dissemination
1
2022
223
0.600
Why?
Public Health
1
2024
566
0.590
Why?
Chemotherapy, Adjuvant
7
2023
421
0.580
Why?
Perioperative Care
1
2021
231
0.580
Why?
Health Planning Guidelines
1
2018
24
0.570
Why?
Preventive Health Services
5
2023
154
0.570
Why?
Retirement
5
2022
35
0.570
Why?
Health Facilities
1
2019
85
0.560
Why?
Spouses
3
2017
108
0.550
Why?
Cost-Benefit Analysis
9
2024
636
0.540
Why?
Diagnostic Imaging
1
2020
339
0.540
Why?
Quality Indicators, Health Care
1
2020
335
0.540
Why?
Survival Analysis
10
2019
1385
0.530
Why?
Reimbursement, Incentive
1
2017
42
0.510
Why?
Healthy People Programs
1
2016
7
0.490
Why?
Occupational Health Services
2
2016
37
0.490
Why?
Bevacizumab
1
2017
167
0.470
Why?
Logistic Models
13
2023
2119
0.470
Why?
Job Satisfaction
3
2013
240
0.470
Why?
Job Description
2
2013
12
0.470
Why?
Triple Negative Breast Neoplasms
3
2023
216
0.460
Why?
Massachusetts
4
2021
180
0.460
Why?
Hematopoietic Stem Cell Transplantation
1
2021
676
0.450
Why?
Outpatients
1
2019
443
0.450
Why?
Length of Stay
6
2012
1337
0.440
Why?
Chronic Pain
1
2019
292
0.440
Why?
State Government
3
2014
46
0.430
Why?
Rectal Neoplasms
1
2016
158
0.430
Why?
Fee-for-Service Plans
4
2023
98
0.430
Why?
Vaginal Smears
1
2014
55
0.430
Why?
Nursing Homes
4
2013
172
0.420
Why?
Longitudinal Studies
11
2022
2947
0.410
Why?
Health Services Research
4
2010
396
0.410
Why?
Mouth Neoplasms
3
2019
90
0.410
Why?
Emergency Treatment
1
2015
124
0.400
Why?
General Practice
1
2014
32
0.400
Why?
Databases, Factual
8
2026
1486
0.400
Why?
Risk Factors
16
2026
10792
0.400
Why?
Sick Leave
2
2019
16
0.390
Why?
Delivery of Health Care
5
2024
947
0.390
Why?
Cross-Sectional Studies
13
2023
5872
0.390
Why?
Sickness Impact Profile
1
2013
62
0.380
Why?
Behavioral Risk Factor Surveillance System
4
2017
59
0.380
Why?
Health Personnel
3
2022
748
0.370
Why?
Diabetes Mellitus, Type 2
4
2015
2584
0.370
Why?
Insurance Claim Review
2
2010
83
0.370
Why?
Marital Status
3
2007
46
0.360
Why?
Value of Life
2
2008
19
0.360
Why?
Homes for the Aged
2
2013
32
0.360
Why?
Work
3
2010
23
0.360
Why?
Cohort Studies
10
2025
5965
0.360
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2023
1958
0.350
Why?
Age Factors
11
2022
3335
0.350
Why?
Colorado
5
2026
4564
0.350
Why?
Survival Rate
7
2020
2092
0.350
Why?
Neoplasm Metastasis
3
2020
695
0.330
Why?
Health Services
1
2012
115
0.330
Why?
Periodicals as Topic
2
2023
203
0.330
Why?
Patient Protection and Affordable Care Act
3
2024
103
0.330
Why?
Hypoglycemia
1
2015
477
0.320
Why?
Quality Improvement
2
2018
1291
0.320
Why?
Physician Self-Referral
1
2010
1
0.320
Why?
Social Class
4
2022
268
0.320
Why?
Surgical Procedures, Operative
2
2012
271
0.320
Why?
Intestinal Perforation
3
2016
44
0.310
Why?
Models, Econometric
6
2017
34
0.300
Why?
Financing, Personal
2
2019
27
0.300
Why?
Biomedical Research
2
2020
710
0.300
Why?
Data Collection
3
2014
635
0.300
Why?
Carcinoma, Squamous Cell
3
2019
642
0.300
Why?
Waiting Lists
1
2011
263
0.300
Why?
Physicians
1
2018
940
0.300
Why?
Astrocytoma
1
2010
129
0.300
Why?
Radiation Oncology
1
2010
89
0.300
Why?
Costs and Cost Analysis
2
2022
220
0.290
Why?
Recovery of Function
1
2013
710
0.290
Why?
Gastrointestinal Hemorrhage
3
2016
136
0.290
Why?
Surveys and Questionnaires
12
2018
6053
0.280
Why?
Administration, Oral
2
2023
848
0.280
Why?
Dentists
1
2008
21
0.280
Why?
Persuasive Communication
1
2008
14
0.280
Why?
Dental Care
1
2008
26
0.280
Why?
Life Expectancy
1
2008
72
0.280
Why?
Oropharyngeal Neoplasms
2
2018
55
0.270
Why?
Multivariate Analysis
9
2019
1540
0.270
Why?
Propensity Score
1
2010
367
0.270
Why?
Odds Ratio
9
2014
1077
0.270
Why?
Stroke
3
2026
1258
0.250
Why?
HIV Infections
2
2022
3154
0.250
Why?
Pneumonectomy
1
2008
169
0.250
Why?
Patient Education as Topic
1
2011
780
0.240
Why?
Confidence Intervals
4
2013
333
0.240
Why?
Likelihood Functions
5
2021
143
0.240
Why?
Women, Working
2
2002
12
0.230
Why?
Quality-Adjusted Life Years
4
2017
121
0.230
Why?
Time Factors
11
2013
7183
0.230
Why?
Online Systems
1
2005
21
0.230
Why?
Depression
4
2021
1559
0.230
Why?
Sex Factors
7
2026
2114
0.230
Why?
Forecasting
6
2020
391
0.220
Why?
Colonic Diseases
2
2016
34
0.220
Why?
Disability Evaluation
1
2007
310
0.220
Why?
Cost Savings
2
2018
86
0.220
Why?
Adolescent
15
2026
22453
0.220
Why?
Treatment Outcome
12
2019
11695
0.220
Why?
Education, Medical, Graduate
1
2010
557
0.220
Why?
Myocardial Infarction
3
2023
1209
0.220
Why?
Cross Infection
2
2017
262
0.210
Why?
Health Services Needs and Demand
3
2017
280
0.210
Why?
Anxiety
3
2021
1110
0.210
Why?
Leukemia, Myeloid, Acute
1
2011
683
0.210
Why?
Methicillin-Resistant Staphylococcus aureus
2
2017
249
0.200
Why?
Referral and Consultation
1
2010
853
0.200
Why?
Models, Statistical
4
2017
682
0.200
Why?
Probability
5
2023
312
0.200
Why?
Needs Assessment
2
2024
404
0.200
Why?
Head and Neck Neoplasms
2
2019
562
0.200
Why?
Hospitals, Public
1
2023
30
0.200
Why?
Time-to-Treatment
1
2025
245
0.200
Why?
Physician-Patient Relations
1
2008
588
0.190
Why?
Community-Based Participatory Research
1
2024
166
0.190
Why?
Substance-Related Disorders
3
1997
1094
0.190
Why?
Economics, Medical
1
2022
6
0.190
Why?
Staphylococcal Infections
2
2017
390
0.190
Why?
Hormones
1
2023
134
0.190
Why?
Age Distribution
4
2020
403
0.180
Why?
Carcinoma
2
2017
228
0.180
Why?
Migraine Disorders
1
2024
112
0.180
Why?
Salaries and Fringe Benefits
1
2002
60
0.180
Why?
Colonic Polyps
2
2014
85
0.180
Why?
Health Behavior
2
2019
786
0.180
Why?
Risk Assessment
6
2022
3676
0.180
Why?
Bisexuality
1
2022
39
0.180
Why?
Smoking
2
2019
1472
0.180
Why?
Hospital Charges
3
2003
46
0.180
Why?
Food Supply
1
2022
90
0.180
Why?
Proportional Hazards Models
5
2019
1325
0.180
Why?
Ambulatory Care Facilities
1
2024
266
0.180
Why?
Incidence
5
2022
2883
0.170
Why?
Insulin, Isophane
1
2001
22
0.170
Why?
Evidence-Based Medicine
2
2016
732
0.170
Why?
Hypoglycemic Agents
3
2018
1389
0.170
Why?
Analgesics, Opioid
2
2021
1143
0.170
Why?
Intensive Care Units
2
2017
916
0.160
Why?
Neoplasm Recurrence, Local
3
2021
1141
0.160
Why?
Brain Neoplasms
1
2010
1322
0.160
Why?
Kentucky
1
2020
39
0.160
Why?
Retrospective Studies
13
2024
17101
0.160
Why?
Exercise
3
2023
2201
0.160
Why?
Homosexuality, Male
1
2022
222
0.160
Why?
Internet
1
2005
700
0.160
Why?
Decision Making
2
2005
980
0.160
Why?
Delayed Diagnosis
1
2020
95
0.160
Why?
Sample Size
1
2000
123
0.150
Why?
Population Surveillance
2
2022
485
0.150
Why?
California
2
2018
475
0.150
Why?
Regression Analysis
5
2021
1003
0.150
Why?
Hospitalization
5
2016
2434
0.150
Why?
Carrier State
2
2017
79
0.150
Why?
Benzodiazepines
1
2021
168
0.150
Why?
Stress, Psychological
2
2021
1153
0.150
Why?
Ownership
2
2010
111
0.150
Why?
Language Development Disorders
1
2019
40
0.150
Why?
Infection Control
2
2017
172
0.140
Why?
Patient Selection
3
2010
719
0.140
Why?
Feasibility Studies
1
2023
1095
0.140
Why?
Anthracyclines
3
2023
47
0.140
Why?
Los Angeles
2
2015
76
0.140
Why?
National Cancer Institute (U.S.)
3
2023
52
0.140
Why?
Patient Care Team
1
2024
689
0.140
Why?
Child
7
2024
22657
0.140
Why?
Exercise Therapy
1
2023
473
0.140
Why?
Diabetes Mellitus
3
2018
1098
0.140
Why?
Taxoids
3
2023
116
0.140
Why?
Activities of Daily Living
2
2010
441
0.140
Why?
Carboplatin
1
2018
160
0.140
Why?
Cetuximab
1
2018
111
0.140
Why?
Radiotherapy, Adjuvant
1
2019
222
0.140
Why?
Cancer Pain
1
2018
36
0.140
Why?
Hyperlipidemias
1
2019
122
0.140
Why?
Ireland
2
2016
32
0.140
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2019
439
0.130
Why?
Research Design
4
2007
1137
0.130
Why?
Infant, Newborn
4
2020
6434
0.130
Why?
Unemployment
2
2009
42
0.130
Why?
Managed Care Programs
1
2018
140
0.130
Why?
Hypertension
2
2024
1264
0.130
Why?
Financing, Government
1
2017
53
0.130
Why?
Accidental Falls
1
2020
222
0.130
Why?
Carcinoma, Intraductal, Noninfiltrating
1
2017
61
0.130
Why?
Public Health Practice
1
2017
63
0.130
Why?
Combined Modality Therapy
4
2019
1268
0.130
Why?
Patient Rights
2
2019
11
0.130
Why?
Hospital Costs
2
2011
124
0.130
Why?
Inpatients
2
2012
546
0.130
Why?
Attitude to Health
3
2019
436
0.130
Why?
Psychiatric Department, Hospital
1
1996
12
0.120
Why?
Patient Discharge
1
2023
983
0.120
Why?
Cisplatin
1
2018
334
0.120
Why?
Drug Therapy
1
2017
80
0.120
Why?
Sex Distribution
3
2020
386
0.120
Why?
Child Behavior
1
1998
236
0.120
Why?
Heart Failure
2
2023
2323
0.120
Why?
Self Efficacy
1
2019
414
0.120
Why?
Lymph Nodes
1
2019
502
0.120
Why?
Language
1
2019
323
0.120
Why?
Ambulatory Surgical Procedures
1
2016
80
0.120
Why?
Smoking Cessation
1
2019
439
0.110
Why?
Neonatal Abstinence Syndrome
1
1996
27
0.110
Why?
Clinical Competence
2
2014
1244
0.110
Why?
Colorectal Surgery
1
2015
27
0.110
Why?
Patient Admission
1
1997
218
0.110
Why?
Minority Groups
1
2017
282
0.110
Why?
Metformin
1
2018
319
0.110
Why?
Residence Characteristics
2
2008
378
0.110
Why?
Child, Preschool
4
2020
11799
0.110
Why?
Case-Control Studies
4
2024
3608
0.110
Why?
Follow-Up Studies
6
2019
5417
0.100
Why?
Mastectomy, Segmental
3
2009
108
0.100
Why?
Antineoplastic Agents, Hormonal
1
2015
194
0.100
Why?
Child Development
1
2019
484
0.100
Why?
National Health Programs
1
2014
23
0.100
Why?
Pennsylvania
2
2024
138
0.100
Why?
Patient Satisfaction
2
2013
705
0.100
Why?
Autism Spectrum Disorder
1
2019
412
0.100
Why?
Systems Integration
1
2013
36
0.100
Why?
Infant
3
2020
10039
0.100
Why?
Bridged-Ring Compounds
2
2023
31
0.100
Why?
Health Status Indicators
1
2014
166
0.100
Why?
Cerebrovascular Disorders
1
2014
103
0.100
Why?
Computer Simulation
2
2023
1026
0.100
Why?
Helping Behavior
1
2013
20
0.100
Why?
Kaplan-Meier Estimate
3
2021
966
0.100
Why?
Pilot Projects
3
2021
1890
0.090
Why?
Quality of Health Care
2
2008
693
0.090
Why?
Medical Audit
1
2013
77
0.090
Why?
Occupations
1
2012
51
0.090
Why?
Mandatory Programs
1
2012
16
0.090
Why?
Intensive Care Units, Neonatal
1
1996
279
0.090
Why?
Insurance, Pharmaceutical Services
1
2012
24
0.090
Why?
Pregnancy, Unwanted
1
2012
15
0.090
Why?
Maryland
3
1997
66
0.090
Why?
Life Tables
2
2008
21
0.090
Why?
Prospective Studies
3
2017
7997
0.090
Why?
Cost Control
1
2012
37
0.090
Why?
Cause of Death
1
2014
472
0.090
Why?
Goals
2
2023
184
0.090
Why?
Self Disclosure
1
2011
62
0.090
Why?
Community Health Services
1
2013
234
0.090
Why?
Contraceptive Agents, Female
1
2012
80
0.090
Why?
Educational Status
1
2013
467
0.090
Why?
Contraception Behavior
1
2012
108
0.090
Why?
Retreatment
1
2011
77
0.080
Why?
Sepsis
1
2017
641
0.080
Why?
Video Recording
1
2011
213
0.080
Why?
Mental Disorders
2
1997
1172
0.080
Why?
Economics, Nursing
1
2010
1
0.080
Why?
Mastectomy
1
2011
162
0.080
Why?
Interinstitutional Relations
1
2010
53
0.080
Why?
Insulin
1
2001
2507
0.080
Why?
Stress, Physiological
1
2013
453
0.080
Why?
Access to Information
1
2010
48
0.080
Why?
Guideline Adherence
1
2014
589
0.080
Why?
Pregnancy Complications
1
1996
592
0.080
Why?
Reproducibility of Results
3
2010
3415
0.080
Why?
Sentinel Surveillance
1
2009
46
0.080
Why?
Consumer Behavior
1
1990
70
0.080
Why?
Bone Marrow Transplantation
1
2011
294
0.080
Why?
Standard of Care
1
2010
80
0.080
Why?
Insurance Claim Reporting
1
2009
26
0.080
Why?
Ohio
1
2009
145
0.070
Why?
Occult Blood
1
2009
40
0.070
Why?
Private Sector
1
2009
50
0.070
Why?
Women's Health
2
2012
310
0.070
Why?
Models, Theoretical
1
2013
582
0.070
Why?
Comparative Effectiveness Research
1
2010
170
0.070
Why?
Physical Exertion
1
2010
207
0.070
Why?
Gastrointestinal Neoplasms
1
2009
70
0.070
Why?
Bias
1
2010
202
0.070
Why?
Linear Models
1
2011
854
0.070
Why?
Home Nursing
1
2008
23
0.070
Why?
Reimbursement Mechanisms
1
2009
80
0.070
Why?
Severity of Illness Index
2
2026
2925
0.070
Why?
Sex Characteristics
2
2022
791
0.070
Why?
Prevalence
2
2020
2836
0.070
Why?
Psychometrics
1
2013
734
0.070
Why?
Education, Professional
1
2008
18
0.070
Why?
Health Care Surveys
1
2010
539
0.070
Why?
Data Interpretation, Statistical
1
2010
372
0.070
Why?
Pain
2
2010
782
0.070
Why?
Radiotherapy
1
2008
206
0.070
Why?
Self Care
1
2010
389
0.060
Why?
Chi-Square Distribution
1
2008
529
0.060
Why?
Pulmonary Disease, Chronic Obstructive
1
2014
923
0.060
Why?
Leukemia
1
2008
245
0.060
Why?
Cognition Disorders
1
2010
538
0.060
Why?
National Institutes of Health (U.S.)
1
2006
143
0.060
Why?
Lung Diseases
1
2012
787
0.060
Why?
Charities
1
2005
13
0.060
Why?
Empirical Research
1
2005
21
0.050
Why?
Hospice Care
1
2007
220
0.050
Why?
Diabetes Mellitus, Type 1
1
2001
3890
0.050
Why?
Diagnosis-Related Groups
1
2003
35
0.050
Why?
Randomized Controlled Trials as Topic
1
2010
1721
0.050
Why?
Florida
2
2014
117
0.050
Why?
Resource Allocation
1
2003
53
0.050
Why?
Pandemics
2
2022
1695
0.050
Why?
Health Surveys
2
2007
518
0.050
Why?
Causality
1
2023
126
0.050
Why?
Social Security
1
2002
5
0.050
Why?
Selection Bias
1
2002
38
0.050
Why?
Markov Chains
2
2017
129
0.050
Why?
Motor Activity
1
2007
722
0.050
Why?
Sampling Studies
1
2002
99
0.050
Why?
Mastectomy, Radical
1
2001
4
0.040
Why?
Interviews as Topic
1
2005
901
0.040
Why?
Diagnostic Tests, Routine
1
2002
108
0.040
Why?
Insulin, Long-Acting
1
2001
65
0.040
Why?
Family Characteristics
1
2002
197
0.040
Why?
Insulin Glargine
1
2001
88
0.040
Why?
Arrhythmias, Cardiac
1
2023
361
0.040
Why?
Normal Distribution
1
2000
22
0.040
Why?
Drug Evaluation
1
2000
79
0.040
Why?
Pancreatic Neoplasms
1
2008
927
0.040
Why?
Diffusion of Innovation
1
2001
98
0.040
Why?
Nursing Research
1
2000
53
0.040
Why?
Clinical Trials as Topic
1
2004
1054
0.040
Why?
Presenteeism
1
2019
6
0.040
Why?
Palliative Care
1
2007
1008
0.040
Why?
Etidronic Acid
1
1998
3
0.040
Why?
Alendronate
1
1998
14
0.040
Why?
Federal Government
1
2018
23
0.040
Why?
Osteoporosis, Postmenopausal
1
1998
40
0.040
Why?
Informed Consent
1
2000
198
0.030
Why?
Spinal Fractures
1
1998
73
0.030
Why?
Receptors, Estrogen
1
2021
457
0.030
Why?
Controlled Before-After Studies
1
2017
15
0.030
Why?
Smoking Prevention
1
1998
166
0.030
Why?
Lymph Node Excision
1
2019
173
0.030
Why?
Lymphatic Metastasis
1
2019
334
0.030
Why?
Estrogen Replacement Therapy
1
1998
144
0.030
Why?
Tennessee
1
2017
54
0.030
Why?
Hyperglycemia
1
2001
375
0.030
Why?
Puberty
1
1998
140
0.030
Why?
Ecosystem
1
2022
589
0.030
Why?
Diagnosis, Dual (Psychiatry)
1
1997
40
0.030
Why?
Patient Isolation
1
2017
20
0.030
Why?
Chemoradiotherapy
1
2018
239
0.030
Why?
Biopsy, Needle
1
2017
183
0.030
Why?
Utilization Review
1
1996
39
0.030
Why?
Arizona
1
1996
81
0.030
Why?
Drug Administration Schedule
1
2018
783
0.030
Why?
Bacteriological Techniques
1
2017
68
0.030
Why?
Patient Dropouts
1
1997
65
0.030
Why?
Schools
1
2000
453
0.030
Why?
Anticholesteremic Agents
1
2018
154
0.030
Why?
Catheter-Related Infections
1
2017
94
0.030
Why?
Epidemiological Monitoring
1
2017
69
0.030
Why?
Dyslipidemias
1
2018
182
0.030
Why?
Health Policy
1
2019
401
0.030
Why?
Alzheimer Disease
1
2002
622
0.030
Why?
Hospitals, Community
1
1996
65
0.030
Why?
Obstetric Labor, Premature
1
1996
39
0.030
Why?
Neoplasm Invasiveness
1
2017
509
0.030
Why?
Health Resources
2
2009
130
0.030
Why?
Antihypertensive Agents
1
2018
511
0.030
Why?
Protoporphyrins
1
1993
14
0.030
Why?
Telemedicine
1
2023
948
0.030
Why?
Learning Curve
1
2014
70
0.020
Why?
Acute Disease
1
1996
1031
0.020
Why?
Lead
1
1993
70
0.020
Why?
Immunohistochemistry
1
2017
1718
0.020
Why?
Sensitivity and Specificity
3
2009
1990
0.020
Why?
Calcium
1
1998
1184
0.020
Why?
Opioid-Related Disorders
1
2021
601
0.020
Why?
Community Participation
1
2013
132
0.020
Why?
Societies, Medical
1
2016
887
0.020
Why?
Risk
1
2014
911
0.020
Why?
Gastroenterology
1
2014
189
0.020
Why?
General Surgery
1
2014
207
0.020
Why?
Pregnancy
2
2012
7191
0.020
Why?
Work Capacity Evaluation
1
2010
11
0.020
Why?
Hepatitis B
1
1991
66
0.020
Why?
Cooperative Behavior
1
2013
465
0.020
Why?
Contraception
1
2012
170
0.020
Why?
Prognosis
1
2019
4293
0.020
Why?
Budgets
1
2009
14
0.020
Why?
Sigmoidoscopy
1
2009
15
0.020
Why?
Leadership
1
2013
409
0.020
Why?
Task Performance and Analysis
1
2010
198
0.020
Why?
Meta-Analysis as Topic
1
2009
174
0.020
Why?
Prostatectomy
1
2009
93
0.020
Why?
Ambulatory Care
1
2013
603
0.020
Why?
Age of Onset
1
2009
551
0.020
Why?
Occupational Exposure
1
1991
354
0.020
Why?
Psychology
1
2008
88
0.020
Why?
Demography
1
2008
288
0.020
Why?
Lifting
1
2006
4
0.010
Why?
Least-Squares Analysis
1
2006
76
0.010
Why?
Illinois
1
2006
47
0.010
Why?
Mortality
1
2008
376
0.010
Why?
Telephone
1
2007
175
0.010
Why?
Body Weight
1
1990
978
0.010
Why?
Patient Compliance
1
2009
589
0.010
Why?
Prejudice
1
2006
60
0.010
Why?
Myocardial Revascularization
1
2003
85
0.010
Why?
Burnout, Professional
1
2010
484
0.010
Why?
Statistics, Nonparametric
1
2003
427
0.010
Why?
Vaccination
1
1991
1423
0.010
Why?
Behavior
1
2002
91
0.010
Why?
Episode of Care
1
2001
7
0.010
Why?
Decision Trees
1
2001
81
0.010
Why?
Drug Prescriptions
1
2002
285
0.010
Why?
Cardiac Catheterization
1
2003
560
0.010
Why?
Reoperation
1
2001
631
0.010
Why?
Neuropsychological Tests
1
2002
1137
0.010
Why?
Drug Therapy, Combination
1
1998
1048
0.010
Why?
Estrogens
1
1998
380
0.010
Why?
Estradiol
1
1998
533
0.010
Why?
Lead Poisoning
1
1993
17
0.010
Why?
Reference Values
1
1993
798
0.010
Why?
ROC Curve
1
1993
615
0.010
Why?
Program Evaluation
1
1991
949
0.000
Why?
Bradley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)